» Articles » PMID: 11331316

Changes in Weight, Body Composition, and Factors Influencing Energy Balance Among Premenopausal Breast Cancer Patients Receiving Adjuvant Chemotherapy

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2001 May 2
PMID 11331316
Citations 183
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Weight gain is a common problem among breast cancer patients who receive adjuvant chemotherapy (CT). We undertook a study to determine the causes of this energy imbalance.

Patients And Methods: Factors related to energy balance were assessed at baseline (within 3 weeks of diagnosis) and throughout 1 year postdiagnosis among 53 premenopausal women with operable breast carcinoma. Thirty-six patients received CT and 17 received only localized treatment (LT). Measures included body composition (dual energy x-ray absorptiometry), resting energy expenditure (REE; indirect calorimetry), dietary intake (2-day dietary recalls and food frequency questionnaires) and physical activity (physical activity records).

Results: Mean weight gain in the LT patients was 1.0 kg versus 2.1 kg in the CT group (P =.02). No significant differences between groups in trend over time were observed for REE and energy intake; however, a significant difference was noted for physical activity (P =.01). Several differences between groups in 1-year change scores were detected. The mean change (+/- SE) in LT versus CT groups and P values for uncontrolled/controlled (age, race, radiation therapy, baseline body mass index, and end point under consideration) analysis are as follows: percentage of body fat (-0.1 +/- 0.4 v +2.2 +/- 0.6%; P =.001/0.04); fat mass (+0.1 +/- 0.3 v +2.3 +/- 0.7 kg; P =.002/0.04); lean body mass (+0.8 +/- 0.2 v -0.4 +/- 0.3 kg; P =.02/0.30); and leg lean mass (+0.5 +/- 0.1 v -0.2 +/- 0.1 kg; P =.01/0.11).

Conclusion: These data do not support overeating as a cause of weight gain among breast cancer patients who receive CT. The data suggest, however, that CT-induced weight gain is distinctive and indicative of sarcopenic obesity (weight gain in the presence of lean tissue loss or absence of lean tissue gain). The development of sarcopenic obesity with evidence of reduced physical activity supports the need for interventions focused on exercise, especially resistance training in the lower body, to prevent weight gain.

Citing Articles

Body weight and body surface area of adult patients with selected cancers: An Italian multicenter study.

Danesi V, Andalo A, Cavallucci M, Balzi W, Gentili N, Altini M PLoS One. 2024; 19(12):e0314452.

PMID: 39689072 PMC: 11651557. DOI: 10.1371/journal.pone.0314452.


Chemotherapy for post-menopausal women with early breast cancer seems not to result in clinically significant changes in thyroid function.

Marina D, Buch-Larsen K, Gillberg L, Andersen M, Andersson M, Rasmussen A Cancer Med. 2024; 13(15):e70015.

PMID: 39108148 PMC: 11303825. DOI: 10.1002/cam4.70015.


A protocol for a multidisciplinary early intervention during chemotherapy to improve dietary management behavior in breast cancer patients: a two-arm, single-center randomized controlled trial.

Tang H, Zhang W, Shen H, Tang H, Cai M, Wang T BMC Cancer. 2024; 24(1):859.

PMID: 39026219 PMC: 11256492. DOI: 10.1186/s12885-024-12623-w.


Myogenic microRNAs as Therapeutic Targets for Skeletal Muscle Mass Wasting in Breast Cancer Models.

Artigas-Arias M, Curi R, Marzuca-Nassr G Int J Mol Sci. 2024; 25(12).

PMID: 38928418 PMC: 11204047. DOI: 10.3390/ijms25126714.


Effects of a combined exercise and dietary intervention on body composition, physical functioning and fatigue in patients with ovarian cancer: results of the PADOVA trial.

Kenkhuis M, Stelten S, Hartman Y, Brouwer C, Tusscher M, van Lonkhuijzen L Br J Cancer. 2024; 131(1):101-109.

PMID: 38720046 PMC: 11231132. DOI: 10.1038/s41416-024-02694-8.